Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 3Other hematologic neoplasm 1Dermatologic 1

Conditions

Lymphoma 3Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell, Cutaneous 2Leukemia, Lymphocytic, Chronic, B-Cell 2Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Neoplasm Metastasis 1Melanoma 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lung Neoplasms 1Leukemia, Prolymphocytic, T-Cell 1Leukemia 1Immunoblastic Lymphadenopathy 1Hematologic Neoplasms 1Glioma 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Breast Neoplasms 1

Interventions

fludarabine phosphate 25Peripheral Blood Stem Cell Transplantation 24Cyclophosphamide 22Whole-Body Irradiation 18Mycophenolic Acid 16Cyclosporine 15Tacrolimus 12Busulfan 12Etoposide 11Antilymphocyte Serum 11Methotrexate 9Melphalan 9Bortezomib 9Rituximab 8Filgrastim 8Carboplatin 7Therapeutics 6Lenalidomide 6Everolimus 6Doxorubicin 6Vorinostat 5Radiotherapy 5Prednisone 5Flow Cytometry 5Alemtuzumab 5tanespimycin 4Vincristine 4Sirolimus 4Psychiatric Rehabilitation 4Paclitaxel 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Immunoblastic Lymphadenopathy × Depsipeptides × Other hematologic neoplasm × Clear all
NCT00963274 2018-04-23

Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Virginia Commonwealth University

Phase 1 Completed
18 enrolled
LymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Leukemia, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡